DOT1L and LSD1 co-bound regions included several critical transcription factors and tumor suppressors (Fig. 5F) and knockout of DOT1L in turn led to reduction of LSD1 binding at these sites (Fig. 5G). Here, DOT1L is linked to neoplasm.